Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Cerebral deposition of the beta-amyloid peptide (A beta) is an invariant feature of Alzheimer's disease. Since the original isolation and characterization of A beta (ref. 1) and the subsequent cloning of its precursor protein, no direct evidence for the actual production of discrete A beta has been reported. Here we investigate whether A beta is present in human biological fluids using antibodies specific for an epitope within A beta that spans the site of normal constitutive cleavage. These antibodies were used to construct a sandwich-type enzyme-linked immunosorbent assay that detects A beta in cerebrospinal fluid, plasma and conditioned medium of human mixed-brain cells grown in vitro (see also ref. 14). By affinity chromatography, we have purified and sequenced A beta and a novel A beta fragment from human cerebrospinal fluid and conditioned medium of human mixed-brain cell cultures. These findings demonstrate that A beta is produced and released both in vivo and in vitro. These observations offer new opportunities for developing diagnostic tests for Alzheimer's disease and therapeutic strategies aimed at reducing the cerebral deposition of A beta.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies that shed light on the physiological role of Aβ in non-diseased brains show that Aβ plays a role in synaptic transmission and is involved in learning and memory formation [18–22].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [18]
In the citing paper
“Recently, we and others have shown that normal processing of the large amyloid f3 protein precursor ({3-APP) secretes 4-kDa A(3 that is readily detected in human cerebrospinal fluid and in medium conditioned by cultured cells (3)(4)(5)(6).”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [3]
In the citing paper
“The demonstration that A-related peptides with the same N terminals as the CTFs documented here are present in conditioned medium of cultured cells (Seubert et al., 1992;Naslund et al., 1994;Simons et al., 1996;Wang et al., 1996;Xu et al., 1998)”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Seubert et al., 1992
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationCleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Self-citationMutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Self-citationChartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J., Farlow, M., Ghetti, B., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,127
Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa-Komaroff, L., Gusella, J. F., & Neve, R. L. (1988) · Nature · doi:10.1038/331528a0 · Cited by 1,096
Cited by
Items 1,401–1,500 of 1,726
Quantification of Alpha-Synuclein in Biological Fluids by Electrochemiluminescence-Based Detection
Kruse, N., & Mollenhauer, B. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9124-2_6 · Cited by 6
Active Site Environment and Reactivity of Copper‐Aβ in Membrane Mimetic SDS Micellar Environment
Dey, C., Roy, M., Ghosh, R., Pal, P., Roy, D., & Dey, S. G. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202401531 · Cited by 6
Mondal, R., Deb, S., Shome, G., Sarkar, V., Lahiri, D., Datta, S. S., & Benito‐León, J. (2024) · Neurología · doi:10.1016/j.nrl.2023.11.005 · Cited by 8
Sakurai, T., Iwasaki, T., Okuno, T., Kawata, Y., & Kise, N. (2011) · Chemical Communications · doi:10.1039/c0cc05668e · Cited by 6
Hyphenated Mass Spectrometry Techniques in the Diagnosis of Amyloidosis
Spodzieja, M., Rodziewicz‐Motowidło, S., & Szymańska, A. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666171003113019 · Cited by 6
Links Between Amyloid and Tau Biology in Alzheimer’s Disease and Their Cholinergic Aspects
Siegel, G. J., Chauhan, N. B., & Karczma, A. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-46526-5_10 · Cited by 6
CELLULAR AND MOLECULAR BIOLOGY OF ALZHEIMER'S DISEASE AND ANIMAL MODELS
Sisodia, S. S., Martin, L. J., Walker, L. C., Borchelt, D., & Price, D. L. (1995) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00276-x · Cited by 7
Molekulare Medizin der Alzheimer-Krankheit
Hoyer, S., Frölich, L., & Sandbrink, R. (1999) · Springer eBooks · doi:10.1007/978-3-662-07096-3_7 · Cited by 10
Biogerontological research in Canada
Fülöp, T. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00086-3 · Cited by 6
Non-cholinergic drug development for Alzheimer's disease
Yaari, R., Kumar, S., & Tariot, P. N. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.7.745 · Cited by 6
Is aggregation of β-amyloid peptides a mis-functioning of a current interaction process?
Festy, F., Lins, L., Péranzi, G., Octave, J. N., Brasseur, R., & Thomas, A. (2001) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(01)00158-3 · Cited by 10
Inhibitory effect of monoclonal antibodies on Alzheimer's β-amyloid peptide aggregation
Hanan, E., & Solomon, B. (1996) · Amyloid · doi:10.3109/13506129609014365 · Cited by 6
Conn, K. J., Papastoitsis, G., Meckelein, B., & Abraham, C. R. (1994) · Amyloid · doi:10.3109/13506129409146114 · Cited by 8
Potential therapeutic targets for Alzheimer’s disease
McKeon‐O'Malley, C., Saunders, A. J., Bush, A. I., & Tanzi, R. E. (1998) · Emerging Therapeutic Targets · doi:10.1517/14728222.2.2.157 · Cited by 8
The Critical Role of Phosphate Buffers in Cellular Function: From Homeostasis to Disease
Hassan, R. Q. U., Tahir, M. M., Waheed, S., Naimat, S., & Ullah, M. S. (2024) · Biology Bulletin Reviews · doi:10.1134/s2079086424600723 · Cited by 5
“CEREBRAL deposition of the β -amyloid peptide (A β ) is an invariant feature of Alzheimer’s disease (Seubert et al., 1992).”
Inherent Adaptivity of Alzheimer Peptides to Crowded Environments
Sio, S. D., Wägele, J., Bhatia, T., Voigt, B., Lilie, H., & Ott, M. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202200527 · Cited by 5
Song, S., Liu, Q., Chen, R., Chen, P., Tao, M., Li, S., Guo, L., Zhu, X., Liu, Y., Liu, L., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02032-w · Cited by 6
Znaczenie cyklooksygenaz w neurotoksyczności peptydów amyloidu β w chorobie Alzheimera
Cąkała, M., & Strosznajder, J. B. (2010) · Neurologia i Neurochirurgia Polska · doi:10.1016/s0028-3843(14)60407-2 · Cited by 7
Computational Insights into Dynamics of Protein Aggregation and Enzyme–Substrate Interactions
Özbil, M., Barman, A., Bora, R. P., & Prabhakar, R. S. (2012) · The Journal of Physical Chemistry Letters · doi:10.1021/jz301597k · Cited by 6
The Function of the Amyloid Precursor Protein Family
Cappai, R., Needham, B. E., & Ciccotosto, G. D. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_3 · Cited by 6
“This releases a large soluble fragment of the ectodomain, termed sAPPβ, and leaves the membrane-associated CTF-β fragment, which contains an intact Aβ sequence [72, 77, 78].”
Ye, S., Zeng, R., Jiang, P., Hou, M., Liu, F., Wang, Z., Du, X., Yuan, J., Chen, Y., Cao, H., et al. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.02.024 · Cited by 7
Churkina, A. S., Shakhov, A. S., Kotlobay, A. A., & Alieva, I. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415533 · Cited by 6
Hyslop, P. A., & Bender, M. H. (2002) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0720s18 · Cited by 5
β-Amyloid precursor protein (APP)-like immunoreactivity in the human sympathetic ganglia
Calzada, B., Cabal, A., Naves, F. J., Soto, M. D. V., Represa, J., & Vega, J. A. (1994) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(94)91588-1 · Cited by 5
Cerebrospinal fluid biomarkers in human prion diseases
Gawinecka, J., & Zerr, I. (2009) · Future Neurology · doi:10.2217/fnl.10.2 · Cited by 7
SPECIFIC MECHANISM FOR BLOOD INFLOW STIMULATION IN BRAIN AREA PRONE TO ALZHEIMER’S DISEASE LESIONS
Ionov, I. D. (2007) · International Journal of Neuroscience · doi:10.1080/00207450601125733 · Cited by 6
“This ability is revealed, in particular, in human fetal mixed-brain cell cultures (Seubert et al., 1992; Haass et al., 1992; Busciglio et al., 1993), in human NT2N cells neuronal culture (Wertkin et al.”
BackgroundComputational Insights into the Development of Novel Therapeutic Strategies for Alzheimer’s Disease
Prabhakar, R. S. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.10 · Cited by 5
The Effects of Glycerophospholipids and Fatty Acids on APP Processing
Mett, J., Hartmann, T., & Grimm, M. O. W. (2016) · Elsevier eBooks · doi:10.1016/b978-1-63067-036-8.00013-5 · Cited by 6
Amyloid β peptide affects erythrocyte morphology: Role of intracellular signaling pathways
Dinarelli, S., Girasole, M., & Misiti, F. (2019) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-199007 · Cited by 5
Neuropathological Correlates of Dementia in Alzheimer’s Disease
Masliah, E., & Salmon, D. P. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_15 · Cited by 8
Potential βPP-processing proteinase activities from alzheimer's and control brain tissues
Ladror, U. S., Wang, G. T., Klein, W. L., Holzman, T. F., & Krafft, G. A. (1994) · Journal of Protein Chemistry · doi:10.1007/bf01901691 · Cited by 8
Regulation of APP Processing by First Messengers
Nitsch, R. M., Growdon, J. H., Farber, S. A., Deng, M., & Wurtman, R. J. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_9 · Cited by 5
Studies of APP Biology: Analysis of APP Secretion and Characterization of an APP Homologue, APLP2
Sisodia, S. S., Slunt, H. H., Koch, C. V., Lo, A., & Thinakaran, G. (1994) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-01135-5_11 · Cited by 5
Alzheimer’s Disease and Hemorrhagic Stroke: Their Relationship to βA4 Amyloid Deposition
Hendriks, L., Cras, P. P., Martin, J., & Broeckhoven, C. V. (1995) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-79423-0_4 · Cited by 5
Molekulare Mechanismen der Alzheimer Erkrankung
Haass, C. (1999) · Springer eBooks · doi:10.1007/978-3-642-60228-3_4 · Cited by 7
Zhang, Z., Drzewiecki, G. J., May, P. C., Rydel, R. E., Paul, S. M., & Hyslop, P. A. (1996) · Amyloid · doi:10.3109/13506129609045515 · Cited by 5
Penke, B., Tóth, L., Soós, K., Varga, J., Szabó, E. Z., Márki-Zay, J., & Baranyi, A. (1995) · Springer eBooks · doi:10.1007/978-94-011-1468-4_36 · Cited by 5
Genetics of Alzheimer's Disease
Bekris, L. M., Yu, C., Bird, T. D., & Tsuang, D. W. (2010) · Wiley eBooks · doi:10.1002/9780470669600.ch43 · Cited by 6
Zhang, Z.-Y., Li, Z., Tang, Y.-H., Hou, T.-T., Xu, L., Wang, Z.-H., Qin, T., Wang, Y., & Zhu, M. (2024) · Talanta · doi:10.1016/j.talanta.2024.126858 · Cited by 4
Prediction of Cerebral Amyloid Pathology Based on Plasma Amyloid and Tau Related Markers
Chen, T., Lin, K., Lin, S., Lee, Y., Lin, Y., Wang, C.-Y., Chen, J., & Wang, P. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.619388 · Cited by 4
Zhu, M., Li, S., Liu, Q., Zhang, Y., Li, Z., Wang, Y., Wu, L., & Jiang, X. (2024) · Aggregate · doi:10.1002/agt2.601 · Cited by 5
Costa, A. C. S. (2024) · Brain Sciences · doi:10.3390/brainsci14111084 · Cited by 5
“The APP gene was sequenced [46], mapped to chromosome 21 [47], and A β was confirmed to be a byproduct of the enzymatic processing of APP [48–51].”
Optimization of the methods for small peptide solution structure determination by NMR spectroscopy
Istrate, A., Mantsyzov, A. B., Kozin, S. A., & Polshakov, V. I. (2010) · Molecular Biology · doi:10.1134/s0026893310060130 · Cited by 4
“Aβ – нормальный компонент биологических жидкостей (кровь, спин номозговая жидкость), где присутствует в сравни тельно низких концентрациях (около 5–20 нМ), ко торые приблизительно одинаковы и для больных и для здоровых людей [7, 8].”
Endosomal pH favors shedding of membrane‐inserted amyloid‐β peptide
Shi, J., Lv, J., Gao, B., Zhang, L., & Ji, S. (2019) · Protein Science · doi:10.1002/pro.3596 · Cited by 5
Yokoyama, K. (2013) · CRC Press eBooks · doi:10.1201/b15615-8 · Cited by 4
Grover, S., Pham, T., Jones, A., Pereira, C. S., Maurino, M. V. D., Garrad, E. C., Makoni, N. J., Parks, A., Domalewski, R. J., Riggio, G., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15817 · Cited by 5
“The first- generation antibodies allowed quantitative measurement of Aβ levels in human tissues and fluids (Seubert et al., 1992), and the second- generation C- terminal- selective Aβ antibodies helped resolve the Aβ40/Aβ42 composition in plaques (Gravina et al., 1995).”
BackgroundThe Aβcentric Pathway of Alzheimer’s Disease
Villemagne, V. L., Cappai, R., Barnham, K. J., Cherny, R. A., Opazo, C., Novakovic, K. E., Rowe, C. C., & Masters, C. L. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_2 · Cited by 17
Specific cleavage of β-amyloid peptides by a metallopeptidase from Xenopus laevis skin secretions
Clamagirand, C., Joulie, C., Panchal, M., Sekhri, R., Hanquez, C., Cohen, P., & Rholam, M. (2002) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s1096-4959(02)00093-3 · Cited by 4
A New Interpretative Paradigm for Conformational Protein Diseases
Agnati, L. F., Guidolin, D., Woods, A. S., Ciruela, F., Carone, C., Vallelunga, A., Escuela, D. O. B., Genedani, S., & Fuxé, K. (2013) · Current Protein and Peptide Science · doi:10.2174/1389203711314020006 · Cited by 5
Modulating Role of TTR in Aβ Toxicity, from Health to Disease
Cardoso, I., Santos, L. M., & Alemi, M. (2016) · InTech eBooks · doi:10.5772/63194 · Cited by 8
Design of Inhibitors of Amyloid-β Misfolding and Aggregation for Alzheimer's Therapy
Estrada, L. D., Lasagna‐Reeves, C. A., & Soto, C. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-71522-3_15 · Cited by 5
“(Seubert et al., 1992).”
Sivaraman, D., Panneersel, P., & Muralidhar, P. (2016) · International Journal of Pharmacology · doi:10.3923/ijp.2016.52.65 · Cited by 7
Liang, Y., Wang, W., Sun, Y. P., & Dong, X. (2021) · Chinese Journal of Chemical Engineering · doi:10.1016/j.cjche.2021.04.018 · Cited by 4
Key Enzymes and Proteins in Amyloid-Beta Production and Clearance
Santos, C. R. A., Cardoso, I., & Gonçalves, I. (2011) · InTech eBooks · doi:10.5772/17646 · Cited by 9
Philippe, B., Brion, J., Coppens, E., & Octave, J. (1996) · Journal of Neuroscience Research · doi:10.1002/jnr.490460602 · Cited by 4
Extracellular Amyloid-β Protein Dynamics in Alzheimer’s Disease
Cirrito, J. R. (2012) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-4815-0_9 · Cited by 4
Multiplexed Detection of Oligonucleotides with Biobarcoded Gold Nanoparticle Probes
Lee, J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-052-2_2 · Cited by 4
Lipids and Lipoproteins in Alzheimer’s Disease
Stukas, S. K., Kulić, I., Zareyan, S., & Wellington, C. L. (2015) · InTech eBooks · doi:10.5772/59808 · Cited by 6
“[108] Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, et al.”
BackgroundMulthaup, G., Dieter, H. H., Beyreuther, K. T., & Bayer, T. A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-288-3_17 · Cited by 5
Molecular Pathobiology of Alzheimer’s Disease
Harrington, C. R., & Wischik, C. M. (1994) · Springer eBooks · doi:10.1007/978-1-4615-6805-6_13 · Cited by 5
Selkoe, D. J. (1995) · Springer eBooks · doi:10.1007/978-3-642-79423-0_7 · Cited by 4
Self-citationHearn, M. G., Edland, S. D., Ogburn, C. E., Smith, A. C., Bird, T. D., Martin, G. M., & Fukuchi, K.-I. (1994) · Experimental Gerontology · doi:10.1016/0531-5565(94)90074-4 · Cited by 4
Cerebral Zinc Metabolism in Alzheimer’s Disease
Atwood, C., Moir, R. D., Huang, X., Tanzi, R. E., & Bush, A. I. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_14 · Cited by 4
Anti-Aβ antibody target engagement: a response to Siemers et al.
Watt, A. D., Crespi, G. A. N., Down, R. A., Ascher, D. B., Gunn, A. P., Perez, K. A., McLean, C., Villemagne, V. L., Parker, M. W., Barnham, K. J., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1333-8 · Cited by 4
Kuentzel, S. L., Gonzalez‐DeWhitt, P. A., Lowery, D. E., Altman, R. A., Leone, J. W., Heinrikson, R. L., Greenberg, B., & Raub, T. J. (1996) · Amyloid · doi:10.3109/13506129609014360 · Cited by 4
Cellular and molecular basis of b-amyloid precursor protein metabolism
Xu, H. (2000) · Frontiers in bioscience · doi:10.2741/a497 · Cited by 5
Corraliza-Gómez, M. (2021) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/51889 · Cited by 6
Brugg, B., Lemaigre‐Dubreuil, Y., Huber, G., Kopmels, B., Delhaye‐Bouchaud, N., Wollman, E. E., & Mariani, J. (1995) · Springer eBooks · doi:10.1007/978-3-642-79423-0_17 · Cited by 4
Staneva, G., Yordanova, V., Danailova, A., Marinovska, A.-M., Dér, A., & Taneva, S. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311361 · Cited by 3
Genomic and proteomic conversion of brain ischemia to Alzheimer’s disease
Pluta, R. M., & Ułamek-Kozioł, M. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1804251 · Cited by 4
“The evidence of no difference in the levels of β -amyloid peptides 1–40 and 1–42 in the blood of patients with sporadic Alzheimer’s disease (Seubert et al., 1992) and the finding of deposits of these peptides in brain parenchyma support the hypothesis that the blood-brain barrier must be damaged…”
Advances in Alzheimer's Disease Biomarkers
Li, K., Gao, Y., Liu, M., & Chen, Y. (2024) · Current Alzheimer Research · doi:10.2174/0115672050366767241223050957 · Cited by 3
Mondal, R., Deb, S., Shome, G., Sarkar, V., Lahiri, D., Datta, S. S., & Benito‐León, J. (2025) · Neurología (English Edition) · doi:10.1016/j.nrleng.2025.03.008 · Cited by 7
Hartl, D., Gu, W., Mayhaus, M., Pichler, S., Schöpe, J., Wagenpfeil, S., & Riemenschneider, M. J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150191 · Cited by 3
A synthetic substrate assay for the gamma‐secretase of the β‐A4 amyloid of alzheimer's disease
Evin, G. M., Beyreuther, K. T., & Masters, C. L. (1995) · Journal of Peptide Science · doi:10.1002/psc.310010205 · Cited by 3
Gao, Q., Fang, Y., Zhang, S., Li, H., Yung, K. K. L., & Lai, K. W. C. (2018) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2018.2800723 · Cited by 3
“In healthy human brains, Aβ1-40 mainly exists in the form of soluble α-helix, and its concentration is maintained at nanomolar level [8].”
BackgroundInnovative SALDI mass spectrometry analysis for Alzheimer's disease synthetic peptides detection
Cournut, A., Moustiez, P., Coffinier, Y., Enjalbal, C., & Bich, C. (2023) · Talanta · doi:10.1016/j.talanta.2023.125357 · Cited by 3
Amyloid beta: Functional protein or biological junk?
Koudinova, N. V., Koudinov, A. R., & Berezov, T. T. (2007) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s199075080703002x · Cited by 3
The potential utility of transgenic mice harboring β-amyloid precursor protein
Schenk, D., Games, K. D., & McConlogue, L. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00081-o · Cited by 5
Self-citationMolecular Imaging in Neurodegenerative Diseases
Kim, J. S., Oh, S. J., & Moon, D. H. (2009) · Journal of Korean Medical Association · doi:10.5124/jkma.2009.52.2.151 · Cited by 3
Expression of Alzheimer's amyloid precursor protein in human lymphocyte
Suh, Y., Choi, W., Kim, S., Kim, J., Rhi, B.-Y., Chong, Y. H., Woo, J. I., & Lee, K. (1997) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(96)00721-2 · Cited by 3
“The discovery that ]3APP is widely expressed in all neuronal and non-neuronal mammalian tissues and that soluble fragments are released from many cell types throughout life indicated that they may possess a normal physiological function (Haass et al., 1992; Seubert et al., 1992) but little is known of the normal funct…”
BackgroundUberti, D. L., Bianchi, I., Olivari, L., Ferrari‐Toninelli, G., Bonini, S. A., & Memo, M. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9350-9 · Cited by 3
“Ab is a 39–43 amino acid length peptide derived from the amyloidogenic processing of the larger amyloid precursor protein (APP) [ 33 ].”
BackgroundAmyloid-ss Dynamics Correlate with Neurological Status in the Injured Human Brain
Brody, D. L., Esparza, T. J., Magnoni, S., Stocchetti, N., Schwetye, K. E., Zipfel, G. J., Spinner, M. L., & Holtzman, D. M. (2009) · International Conference on Bioinformatics and Biomedical Engineering · doi:10.1109/icbbe.2009.5162305 · Cited by 3
Methionine 35 sulphoxide reduces toxicity of Aβ in red blood cell
Carelli‐Alinovi, C., & Misiti, F. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12735 · Cited by 3
Honda, R. P. (2018) · Angewandte Chemie · doi:10.1002/ange.201800197 · Cited by 3
Pathology, Neurobiology, and Animal Models of Alzheimer's Disease
Sisodia, S. S., Price, D. D., Crain, B. J., & Troncoso, J. C. (1996) · Informa Healthcare eBooks · doi:10.1201/9781420048407.ch12 · Cited by 3
Tau and beta-amyloid in Alzheimer’s Disease: Theories, treatments strategies, and future directions
Colautti, J., & Nagales, K. (2020) · The Meducator · doi:10.15173/m.v1i37.2502 · Cited by 3
Chapter 4. Emerging themes in Alzheimer's disease research: Paradigm shift in drug discovery
Morgan, T. E., & Krafft, G. A. (2002) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(02)37005-2 · Cited by 3
Capell, A., Teplow, D. B., Citron, M., Selkoe, D. J., & Haass, C. (1996) · Amyloid · doi:10.3109/13506129609045514 · Cited by 5
Self-citationDeGiorgio, L. A., Bernstein, J. J., Manuelidis, L., & Blass, J. P. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01175-4 · Cited by 4
Proceedings: Listeria monocytogenes-haemolysin: lecithinase.
Khan, M. J., Seaman, A., & Woodbine, M. (1972) · PubMed · Cited by 3
Chen, J., Han, X., Liu, Z., Zhou, C., Hu, R., Tabassam, S., Wyatt-Johnson, S. K., Oblak, A. L., Brutkiewicz, R. R., Lin, M., et al. (2026) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2025.3614233 · Cited by 2
Diversity of Aβ aggregates produced in a gut-based Drosophila model of Alzheimer’s disease
Elovsson, G., Klingstedt, T., Nilsson, K. P. R., & Brorsson, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0314832 · Cited by 2
Sambamurti, K. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60569-0 · Cited by 2
Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease
Sur, T. K., Mondal, T., Noreen, Z., Johnson, J., Nunlee‐Bland, G., Loffredo, C. A., Korba, B. E., Chandra, V., Jana, S. S., Kwabi‐Addo, B., et al. (2025) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2025.100120 · Cited by 4
“Ever since their identification in CSF, amyloid protein (Seubert et al., 1992) and the tau protein (Vandermeeren et al., 1993) continue to be considered as the gold standard biomarkers for the diagnosis of AD.”
DNA Binding of a Molecular‐Scale Receptor in the Presence of Zinc( II ) Ions
Benniston, A. C., Harriman, A., Lawrie, D. J., & Mehrabi, M. (2005) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200400813 · Cited by 2
Li, Q., & Masters, C. L. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50805-3 · Cited by 2
Evaluación de la producción de b-amiloide por la mutación E280A en el gen de la presenilina 1
Villegas, A., Castañeda, M. M., Arias, L. F., Vieco, B., Lopera, F. J., & Bedoya, G. (2007) · Biomédica · doi:10.7705/biomedica.v27i3.200 · Cited by 2
The Amyloid _-Protein and Alzheimer's Disease
Teplow, D. B., Yang, M., Roychaudhuri, R., Pang, E. S., Huynh, T. V., Chen, M., & Beroukhim, S. (2012) · Frontiers in neuroscience · doi:10.1201/b11986-2 · Cited by 2
Meraz‐Ríos, M. A., & Leal‐Galicia, P. (2016) · InTech eBooks · doi:10.5772/64357 · Cited by 2
“[5], who demonstrated that Aβ fragment comprising the amino acids 13– 28 can be detected in cerebrospinal fluid and plasma of several species including human as well as in conditioned media from human brain cell cultures.”
BackgroundGenetic heterogeneity of gene defects responsible for familial Alzheimer disease
Tanzi, R. E., Gaston, S. M., Bush, A. I., Romano, D., Pettingell, W. H., Peppercorn, J. M., Paradis, M. D., Gurubhagavatula, S., Jenkins, B., & Wasco, W. (1994) · Contemporary issues in genetics and evolution · doi:10.1007/978-94-017-1671-0_24 · Cited by 2
Metadata
- Authors
- Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., & Schenk, D.
- Affiliations
- Austrian Academy of Sciences (AT)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6393
- Pages
- 325-327
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086278983
- Cited by
- 1,731
- References
- 28
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 32 · 2023: 19 · 2022: 22 · 2021: 31 · 2020: 28 · 2019: 25 · 2018: 35 · 2017: 39 · 2016: 31 · 2015: 48 · 2014: 46 · 2013: 39 · 2012: 50
- FWCI
- 72.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, cerebrospinal fluid, plasma, conditioned medium, sandwich ELISA, affinity chromatography, epitope-specific antibodies, amyloid deposition, diagnostic biomarkers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Antibodies, Monoclonal, Brain, Cells, Cultured, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Humans, Molecular Sequence Data, Peptide Fragments, Radioimmunoassay, Solubility, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.